メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
原田 将英
医学部・循環器内科学
h-index
4670
被引用数
25
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2003
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(69)
類似のプロファイル
(6)
フィンガープリント
Masahide Haradaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Atrial Fibrillation
100%
Catheter Ablation
70%
Heart Failure
38%
Catheter Ablation
36%
Atrial Fibrillation Ablation
27%
Heart Failure with Reduced Ejection Fraction
25%
Antithrombotic
22%
Acute Decompensated Heart Failure
21%
Pulmonary Vein Isolation
20%
D-Dimer
20%
Heart Left Ventricle Ejection Fraction
19%
Sinus Rhythm
15%
Brain Natriuretic Peptide
15%
Apoplexy
15%
Cardiovascular System
14%
Persistent Atrial Fibrillation
14%
Creatinine
13%
Ventricular Fibrillation
12%
Ventricular Tachycardia
12%
Heart Atrium Remodeling
12%
Pathophysiology
12%
Recurrent Disease
12%
Major Bleeding
11%
Transient Ischemic Attack
11%
Observational Study
11%
Ablation Therapy
11%
Urinary System
11%
Sustained Ventricular Tachycardia
11%
Heart Failure with Preserved Ejection Fraction
10%
Anticoagulation
10%
Bone Mass
9%
Antiapoptotic
9%
Midkine
9%
Apolipoprotein E
9%
Calcium Signaling
9%
Amino Terminal Sequence
9%
Oxygen Desaturation
9%
Acute Kidney Injury
9%
Protein Z
9%
Systolic Heart Failure
9%
Mobilization
9%
Defibrillator
9%
Intracardiac Echocardiography
9%
Permanent Atrial Fibrillation
9%
T Wave
9%
Takotsubo Cardiomyopathy
9%
Bepridil
9%
Life Expectancy
9%
Spiral Wave
9%
RNA Synthesis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Atrial Fibrillation
77%
Heart Failure
32%
Heart Failure with Reduced Ejection Fraction
25%
Inflammation
23%
Acute Heart Failure
21%
Midkine
19%
Rivaroxaban
19%
Congestive Heart Failure
19%
Direct Oral Anticoagulant
19%
Anticoagulant Agent
16%
Brain Natriuretic Peptide
15%
Creatinine
15%
Heart Ventricle Tachycardia
13%
Pathophysiology
13%
Antiapoptotic
12%
Recurrent Disease
12%
Systolic Heart Failure
11%
Leporidae
11%
D Dimer
11%
Observational Study
11%
Heart Failure with Preserved Ejection Fraction
10%
Thromboembolism
10%
Apolipoprotein E Knockout Mouse
9%
Life Expectancy
9%
Rotigaptide
9%
Left Ventricular Systolic Dysfunction
9%
Acute Kidney Failure
9%
Fatty Acid Binding Protein
9%
Bepridil
9%
Adverse Outcome
9%
Sodium Ion
9%
Amiodarone
9%
Reentry Arrhythmia
9%
Acetylsalicylic Acid
9%
Heart Ventricle Remodeling
9%
Idarucizumab
9%
Cardiac Sarcoidosis
9%
Pilsicainide
9%
Transient Receptor Potential Channel 3
9%
Fibrosis
9%
Calcium Ion
9%
Cardiovascular Disease
9%
Protein Kinases
9%
Verapamil
9%
Biological Marker
9%
Bleeding
9%
Transient Ischemic Attack
8%
Apolipoprotein E
8%
Tetrylammonium
6%
Symptom
5%
Keyphrases
Cardiac Intensive Care Unit
19%
Cardiac Fibroblasts
11%
Angiogenic
9%
Atherosclerotic Plaque Rupture
9%
Calcium Handling
9%
Metabolic Adaptation
9%
Apolipoprotein E Knockout Mice
9%
Cell Calcium
9%
CAMP-dependent Protein Kinase
9%
Small RNA Sequencing
9%
Atrial Fibrillation Progression
9%
Adenosine Monophosphate
9%
Multiple Wavelet
9%
Anti-apoptotic
9%
Midkine
9%
MicroRNA Regulation
9%
Disease Potential
9%
Fatty
9%
Cardiac Disease
9%
Signaling Role
9%
Calcium Signaling
9%
Telemonitoring
9%
Pulmonary Tumor Thrombotic Microangiopathy
9%
SK Channels
9%
Atrial Electrophysiology
9%
Prognostic Importance
9%
Urinary Liver-type Fatty Acid Binding Protein
9%
Oxygen Desaturation
9%
Atrial Fibrillation
9%
Intracardiac Echocardiography
9%
Multiscale Entropy
9%
Ablation Index
9%
Wave Collision
9%
Spiral Wave
9%
Adverse Outcomes
9%
Moderate Hypothermia
9%
Takotsubo Cardiomyopathy
9%
Electrical Coupling
9%
Bepridil
9%
Oral Anticoagulant Therapy
9%
Spiral Wave Reentry
9%
Wearable Cardioverter Defibrillator
9%
Intracellular Angiotensin
9%
Angiotensin II Type 1 Receptor (AT1R)
9%
Rotor
9%
RNA Synthesis
9%
Amiodarone
9%
Unpinning
9%
Collagen Secretion
9%
Acute Kidney Injury
9%
